Skip to main content

Nistico Robert's Form 4 filing

Endovia Health Sciences, Inc. (EDVA) · filed May 31, 2022

Accession no.
0001731122-22-001019
Filed
May 31, 2022
Trade date
May 26-27, 2022
Filing delay
5 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions. Open-market purchases total $22.0K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Nistico RobertCIK 0001797597Director, Officer (CEO and Chairman)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 26, 2022Common StockPPurchaseAcquired+1,000$1.94+$1,9401,311,070Direct
May 26, 2022Common StockPPurchaseAcquired+2,000$1.99+$3,9801,313,070Direct
May 26, 2022Common StockPPurchaseAcquired+2,000$1.95+$3,9001,315,070Direct
May 26, 2022Common StockPPurchaseAcquired+2,000$1.95+$3,9001,317,070Direct
May 27, 2022Common StockPPurchaseAcquired+2,000$2.12+$4,2401,319,070Direct
May 27, 2022Common StockPPurchaseAcquired+1,000$2.03+$2,0301,320,070Direct
May 27, 2022Common StockPPurchaseAcquired+1,000$2.04+$2,0401,321,070Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)